10 Cancer Screening Timelines by Type That Catch Problems Early

7. Ovarian Cancer Screening - Limited Options and High-Risk Focus

Ovarian cancer screening presents unique challenges because effective screening methods for the general population remain elusive, leading to focused efforts on high-risk women who may benefit from intensive surveillance protocols. Unlike many other cancers, there are currently no recommended routine screening tests for ovarian cancer in average-risk women, as neither CA-125 blood tests nor transvaginal ultrasounds have proven effective at reducing mortality in this population. The primary screening timeline focuses on women at high risk due to BRCA1 or BRCA2 mutations, Lynch syndrome, or strong family histories of ovarian or breast cancer. For these high-risk women, screening typically begins between ages 30-35 and may include transvaginal ultrasounds and CA-125 measurements every 6-12 months, though the effectiveness of this approach remains uncertain. Many high-risk women ultimately choose prophylactic bilateral salpingo-oophorectomy (removal of ovaries and fallopian tubes) after completing childbearing, typically recommended between ages 35-40 for BRCA1 carriers and 40-45 for BRCA2 carriers. Recent research has shifted focus toward the fallopian tubes as the likely origin of many "ovarian" cancers, leading to investigations of salpingectomy (removal of fallopian tubes while preserving ovaries) as a risk-reduction strategy. The lack of effective screening options underscores the importance of recognizing symptoms such as bloating, pelvic pain, difficulty eating, and urinary urgency, particularly when they are persistent and represent a change from normal. Genetic counseling and testing play crucial roles in identifying high-risk women who might benefit from enhanced surveillance or prophylactic surgery.